檢索結果 - John F. Kokai–Kun

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of <i>Staphylococcus aureus</i>

    Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of <i>Staphylococcus aureus</i> 由 Caroline M. Kusuma, John F. Kokai–Kun

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Deletion analysis of the Clostridium perfringens enterotoxin

    Deletion analysis of the Clostridium perfringens enterotoxin 由 John F. Kokai–Kun, Bruce A. McClane

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model

    Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model 由 John F. Kokai–Kun, Tanya Chanturiya, J J Mond

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice

    Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice 由 John F. Kokai–Kun, Tanya Chanturiya, James J. Mond

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Lysostaphin Cream Eradicates <i>Staphylococcus aureus</i> Nasal Colonization in a Cotton Rat Model

    Lysostaphin Cream Eradicates <i>Staphylococcus aureus</i> Nasal Colonization in a Cotton Rat Model 由 John F. Kokai–Kun, S. M. Walsh, Tanya Chanturiya, James J. Mond

    出版 2003
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Lysostaphin Disrupts <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> Biofilms on Artificial Surfaces

    Lysostaphin Disrupts <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> Biofilms on Artificial Surfaces 由 Julie A. Wu, Caroline M. Kusuma, James J. Mond, John F. Kokai–Kun

    出版 2003
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    COVID-19 vaccine platforms: Delivering on a promise?

    COVID-19 vaccine platforms: Delivering on a promise? 由 Mark Verdecia, John F. Kokai–Kun, Maura Kibbey, Sarita Acharya, Jaap Venema, Fouad Atouf

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens

    Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens 由 John F. Kokai–Kun, J. Glenn Songer, John R. Czeczulin, Fei Chen, Bruce A. McClane

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Catalase (KatA) and Alkyl Hydroperoxide Reductase (AhpC) Have Compensatory Roles in Peroxide Stress Resistance and Are Required for Survival, Persistence, and Nasal Colonization in<i>Staphylococcus aureus</i>

    Catalase (KatA) and Alkyl Hydroperoxide Reductase (AhpC) Have Compensatory Roles in Peroxide Stress Resistance and Are Required for Survival, Persistence, and Nasal Colonization in... 由 Kate Cosgrove, Graham Coutts, Ing‐Marie Jonsson, Andrej Tarkowski, John F. Kokai–Kun, James J. Mond, Simon J. Foster

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial

    Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial 由 John F. Kokai–Kun, Tracey Roberts, Olivia Coughlin, Chenxiong Le, Heidi Whalen, Ralph W. Stevenson, Vincent J. Wacher, Joseph Sliman

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    The Staphylococcus aureus Surface Protein IsdA Mediates Resistance to Innate Defenses of Human Skin

    The Staphylococcus aureus Surface Protein IsdA Mediates Resistance to Innate Defenses of Human Skin 由 Simon R. Clarke, Ramlan Mohamed, Bian Li, Alexander F. Routh, John F. Kokai–Kun, James J. Mond, Andrej Tarkowski, Simon J. Foster

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of <i>Staphylococcus aureus</i>

    Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of <i>Staphylococcus aureus</i> 由 Melanie R. Stapleton, Malcolm J. Horsburgh, Emma J. Hayhurst, Lynda Wright, Ing‐Marie Jonsson, Andrej Tarkowski, John F. Kokai–Kun, James J. Mond, Simon J. Foster

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies

    The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies 由 John F. Kokai–Kun, Tracey Roberts, Olivia Coughlin, Éric Sicard, Marianne Rufiange, Richard N. Fedorak, Christian Carter, Marijke H. Adams, James Longstreth, Heidi Whalen, Joseph Sliman

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates

    Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevent... 由 Leonard E. Weisman, Helen Thackray, Joseph A. Garcia‐Prats, Mirjana Nesin, Joseph H. Schneider, Jennifer Fretz, John F. Kokai–Kun, James J. Mond, William G. Kramer, G. Fischer

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

    Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection 由 Michael Kaleko, J. Andrew Bristol, Steven Hubert, Todd B. Parsley, Giovanni Widmer, Saul Tzipori, Poorani Subramanian, Nur A. Hasan, Perrti Koski, John F. Kokai–Kun, Joseph Sliman, Annie Jones, Sheila Connelly

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Identification of In Vivo–Expressed Antigens of<i>Staphylococcus aureus</i>and Their Use in Vaccinations for Protection against Nasal Carriage

    Identification of In Vivo–Expressed Antigens of<i>Staphylococcus aureus</i>and Their Use in Vaccinations for Protection against Nasal Carriage 由 Simon R. Clarke, Kirsten J. Brummell, Malcolm J. Horsburgh, Philip W. McDowell, Sharifah Aminah Syed Mohamad, Melanie R. Stapleton, Jorge Luis Arroyo-Acevedo, Robert C. Read, Nicholas P. J. Day, Sharon J. Peacock, James J. Mond, John F. Kokai–Kun, Simon J. Foster

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: